Artwork for Figure 1 in the review article "Antibody-drug conjugates: a clinical pharmacy perspective on an emerging cancer therapy" published in the journal Pharmacotherapy, 36(1): 99-116, by Jerjian TV, Glode AE, Thompson LA, and O’Bryant CL. Cancer drugs can be conjugated to antibodies that recognize specific proteins on the surface of cancer cells. This allows a much more targeted approach to specifically kill cancer cells while reducing the toxicity associated with traditional chemotherapy. When it works anyway...